SC 13G Filing

Company

Vistagen Therapeutics, Inc.

Filed

March 8, 2019

Accession Number

0001415889-19-000287

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →